Loading...
MaxCyte, Inc.
MXCT•NASDAQ
Healthcare
Medical - Devices
$2.25
$-0.02(-0.88%)
MaxCyte, Inc. (MXCT) Financial Performance & Income Statement Overview
Review MaxCyte, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-6.44%
↓ 6.44%
Operating Income Growth
-6.00%
↓ 6.000%
Net Income Growth
-8.26%
↓ 8.26%
Operating Cash Flow Growth
-27.32%
↓ 27.32%
Operating Margin
-133.05%
↓ 133.05%
Gross Margin
78.16%
↑ 78.16%
Net Profit Margin
-110.92%
↓ 110.92%
ROE
-19.89%
↓ 19.89%
ROIC
-23.08%
↓ 23.08%
MaxCyte, Inc. (MXCT) Income Statement & Financial Overview
Review MaxCyte, Inc.'s (MXCT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $8.69M | $8.16M | $10.43M | $11.34M |
| Cost of Revenue | $2.28M | $1.93M | $2.52M | $2.47M |
| Gross Profit | $6.41M | $6.24M | $7.91M | $8.87M |
| Gross Profit Ratio | $0.74 | $0.76 | $0.76 | $0.78 |
| R&D Expenses | $4.61M | $5.32M | $5.62M | $6.68M |
| SG&A Expenses | $13.68M | $13.95M | $14.23M | $14.44M |
| Operating Expenses | $19.31M | $20.29M | $19.85M | $21.11M |
| Total Costs & Expenses | $20.57M | $22.22M | $22.37M | $23.58M |
| Interest Income | $2.30M | $2.50M | $2.59M | $2.75M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.53M | $1.07M | $1.08M | $1.11M |
| EBITDA | -$11.37M | -$12.99M | -$10.89M | -$11.16M |
| EBITDA Ratio | -$1.31 | -$1.59 | -$1.04 | -$0.98 |
| Operating Income | -$12.90M | -$14.05M | -$11.94M | -$12.24M |
| Operating Income Ratio | -$1.48 | -$1.72 | -$1.14 | -$1.08 |
| Other Income/Expenses (Net) | $2.30M | $2.50M | $2.59M | $2.75M |
| Income Before Tax | -$10.60M | -$11.56M | -$9.38M | -$9.53M |
| Income Before Tax Ratio | -$1.22 | -$1.42 | -$0.90 | -$0.84 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.07M |
| Net Income | -$10.60M | -$11.56M | -$9.38M | -$9.53M |
| Net Income Ratio | -$1.22 | -$1.42 | -$0.90 | -$0.84 |
| EPS | -$0.10 | -$0.11 | -$0.09 | -$0.09 |
| Diluted EPS | -$0.10 | -$0.11 | -$0.09 | -$0.09 |
| Weighted Avg Shares Outstanding | $105.55M | $105.11M | $104.64M | $104.09M |
| Weighted Avg Shares Outstanding (Diluted) | $105.55M | $105.11M | $104.64M | $104.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan